Drystone LLC Acquires Shares of 3,149 Mettler-Toledo International Inc. (NYSE:MTD)

Drystone LLC acquired a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 3,149 shares of the medical instruments supplier’s stock, valued at approximately $3,853,000. Mettler-Toledo International comprises about 3.8% of Drystone LLC’s portfolio, making the stock its 12th biggest holding.

Other institutional investors have also recently made changes to their positions in the company. DT Investment Partners LLC boosted its position in Mettler-Toledo International by 13.3% in the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after purchasing an additional 8 shares during the last quarter. UMB Bank n.a. raised its stake in shares of Mettler-Toledo International by 8.0% during the 3rd quarter. UMB Bank n.a. now owns 122 shares of the medical instruments supplier’s stock worth $183,000 after purchasing an additional 9 shares during the period. Suncoast Equity Management boosted its holdings in shares of Mettler-Toledo International by 2.0% in the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after buying an additional 9 shares during the last quarter. Bleakley Financial Group LLC grew its position in Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock valued at $1,135,000 after buying an additional 9 shares during the period. Finally, Huntington National Bank increased its holdings in Mettler-Toledo International by 20.0% during the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after buying an additional 9 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Activity

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Down 1.1 %

Shares of NYSE MTD opened at $1,338.58 on Thursday. The business has a 50-day simple moving average of $1,257.26 and a two-hundred day simple moving average of $1,343.51. Mettler-Toledo International Inc. has a 52 week low of $1,133.46 and a 52 week high of $1,546.93. The company has a market cap of $28.24 billion, a P/E ratio of 36.09, a P/E/G ratio of 4.19 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. Equities research analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Analyst Upgrades and Downgrades

MTD has been the subject of a number of research reports. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Robert W. Baird reduced their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Wells Fargo & Company lowered their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Finally, Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their price objective for the company from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $1,351.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.